MARKER THERAPEUTICS, INC. Accounts Payable and Accrued Liabilities, Fair Value Disclosure
MARKER THERAPEUTICS, INC. (MRKR) had Accounts Payable and Accrued Liabilities, Fair Value Disclosure of $967.36 thousand as of 2015-12-31, per its 10-K filed 2016-04-14.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures
us-gaap:AccountsPayableAndAccruedLiabilitiesFairValueDisclosure · last filed 2016-04-14
- 2015-12-31: Accounts Payable and Accrued Liabilities, Fair Value Disclosure $967.36K.
- 2015-09-30: Accounts Payable and Accrued Liabilities, Fair Value Disclosure $874.63K.
- 2015-06-30: Accounts Payable and Accrued Liabilities, Fair Value Disclosure $842.68K.
- 2015-03-31: Accounts Payable and Accrued Liabilities, Fair Value Disclosure $703.32K.
| Period end | Accounts Payable and Accrued Liabilities, Fair Value Disclosure |
|---|---|
| 2015-12-31 | $967.36K 10-K · filed 2016-04-14 |
| 2015-09-30 | $874.63K 10-Q/A · filed 2016-04-14 |
| 2015-06-30 | $842.68K 10-Q/A · filed 2016-04-14 |
| 2015-03-31 | $703.32K 10-Q/A · filed 2016-04-14 |
| 2014-12-31 | $693.36K 10-Q/A · filed 2016-04-14 |
| 2014-03-31 | $3.87M 10-Q/A · filed 2014-05-21 |
| 2013-12-31 | $3.78M 10-Q/A · filed 2014-05-21 |
| 2013-09-30 | $1.46M 10-Q · filed 2013-11-19 |
| 2013-03-31 | $1.90M 10-Q/A · filed 2013-08-19 |
| 2012-12-31 | $1.94M 10-K/A · filed 2014-04-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |